- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT02724891
Web-based Validation Pelvic Floor Questionnaires
Validation of Electronic (Web-based and Smartphone) Administration of Measures of Pelvic Floor Dysfunction
Studieoversigt
Status
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
Health questionnaires and health diaries are two forms of patient-reported outcomes (PRO) commonly used in healthcare. Health questionnaires are often used as intake logs, discerning and recording the symptoms and severity of a problem at the time of presentation. Health diaries, in contrast, are ongoing logs which allow for mindful attention to symptoms and monitoring of response to therapy. Unfortunately, both types of PRO forms are often under-utilized or uninterpretable because they are collected on paper. Within urogynecology, PRO scales such as the Pelvic Floor Distress Inventory (PFDI), Pelvic Floor Impact Questionnaire (PFIQ), Bristol Stool Chart, Bladder Diaries and others are used ubiquitously. Their impact, however, is diminished by poor compliance and recall bias. The move towards electronic PRO measures would be endorsed by patients (who can track and interact with their data), physicians (who can track progress and study group outcomes) and by regulators (who want to ensure accurate and reproducible data collection). Electronic PRO tools, particularly on the patient's own device, would allow for increased rate of reporting through mobile availability, time stamping of data to prevent recall bias and reduction in data entry mistakes and costs.
Study Procedures After informed consent is obtained, demographic data will be collected. Subjects will be administered the questionnaires either in paper or web-based or smartphone form based on a random number block scheme. At least two weeks later but prior to treatment they will complete the other form of the questionnaire. This can occur at their next office visit or can be completed at home. Subjects will be emailed and/or called by research staff to remind them to complete the second set of questionnaires.
Undersøgelsestype
Tilmelding (Faktiske)
Kontakter og lokationer
Studiesteder
-
-
Alberta
-
Calgary, Alberta, Canada, T2N 1N4
- University of Calgary
-
-
-
-
Arkansas
-
Fayetteville, Arkansas, Forenede Stater, 72701
- University of Arkansas
-
-
New York
-
New York, New York, Forenede Stater, 10032
- Columbia University Irving Medical Center
-
-
Texas
-
Houston, Texas, Forenede Stater, 77030
- Houston Methodist Hospital
-
-
Wisconsin
-
Madison, Wisconsin, Forenede Stater, 53726
- University of Wisconsin School of Medicine and Public Health
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Prøveudtagningsmetode
Studiebefolkning
This is a prospective validation study. Subjects will be recruited at their visit to the Female Pelvic Medicine and Reconstructive Surgery offices and clinics at Columbia and Cornell. Demographic information will be collected at the initial visit/enrollment including age, race, parity, and presenting complaint.
Questionnaires will be administered based on a randomization scheme. These include:
- Pelvic Floor Disorders Inventory short form (PFDI-20)
- Pelvic Floor Impact Questionnaire (PFIQ-7)
- Pelvic Organ Prolapse/Urinary Incontinence Sexual Function Questionnaire (PISQ-12)
- Bristol Stool Scale (BSS)
Questionnaires will be administered via paper-based form, web-based, or smartphone app based on randomization scheme.
Beskrivelse
Inclusion Criteria:
- Women at least 18 years of age presenting with pelvic floor dysfunction
Exclusion Criteria:
- Unable to repeat questionnaires or return to the office in 2 weeks
- No access to computer/web or smartphone
- Pregnancy (as gestational age will advance during 2 week time interval and symptoms may change)
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Observationsmodeller: Case-Crossover
- Tidsperspektiver: Fremadrettet
Kohorter og interventioner
Gruppe / kohorte |
Intervention / Behandling |
---|---|
Arm 1 paper form first
paper questionnaires first then web/smart phone questionnaires after a 2-week washout period
|
questionnaires in paper form
questionnaires in web/smartphone
|
Arm 2 web/smartphone form first
web/smart phone questionnaires first then paper questionnaires after a 2-week washout period
|
questionnaires in paper form
questionnaires in web/smartphone
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
---|---|---|
Test-retest reliability of PFDI-20 in the electronic format
Tidsramme: minimum 2 week interval until subject receives treatment for the condition or up to one year
|
Subjects will complete the paper and either web-based or smartphone versions of the PFDI-20 with at least a 2 week interval between administration of the 2 versions.
|
minimum 2 week interval until subject receives treatment for the condition or up to one year
|
Test-retest reliability of PFIQ-7 in the electronic format
Tidsramme: minimum 2 week interval until subject receives treatment for the condition or up to one year
|
Subjects will complete the paper and either web-based or smartphone versions of the PFIQ-7 with at least a 2 week interval between administration of the 2 versions.
|
minimum 2 week interval until subject receives treatment for the condition or up to one year
|
Test-retest reliability of PISQ-12 in the electronic format
Tidsramme: minimum 2 week interval until subject receives treatment for the condition or up to one year
|
Subjects will complete the paper and either web-based or smartphone versions of the PISQ-12 with at least a 2 week interval between administration of the 2 versions.
|
minimum 2 week interval until subject receives treatment for the condition or up to one year
|
Test-retest reliability of BSS in the electronic format
Tidsramme: minimum 2 week interval until subject receives treatment for the condition or up to one year
|
Subjects will complete the paper and either web-based or smartphone versions of the BSS with at least a 2 week interval between administration of the 2 versions.
|
minimum 2 week interval until subject receives treatment for the condition or up to one year
|
Samarbejdspartnere og efterforskere
Sponsor
Samarbejdspartnere
Efterforskere
- Ledende efterforsker: Cara Grimes, MD, Columbia University
Publikationer og nyttige links
Datoer for undersøgelser
Studer store datoer
Studiestart
Primær færdiggørelse (Faktiske)
Studieafslutning (Faktiske)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Skøn)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Nøgleord
Andre undersøgelses-id-numre
- AAAO8451
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
produkt fremstillet i og eksporteret fra U.S.A.
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Bækkenbundsdysfunktion
-
Stimdia Medical, Inc.AfsluttetVentilator-induceret diaphragmatic dysfunction (VIDD)Irland, Tjekkiet
-
Riphah International UniversityRekruttering
-
Assiut UniversityTrukket tilbagePelvic Congestive SyndromeEgypten
-
The Whiteley ClinicBauerfeindRekrutteringPelvic Congestive SyndromeDet Forenede Kongerige
-
Nationwide Children's HospitalEunice Kennedy Shriver National Institute of Child Health and Human Development...RekrutteringPædiatrisk Sepsis-induceret Multiple Organ Dysfunction SyndromeForenede Stater
-
University of WaterlooAfsluttetMeibomian Gland Dysfunction (MGD)Canada
-
Grand Valley State UniversityTilmelding efter invitationMetabolic Associated-dysfunction Steatotic Lever Disease (MASLD) | Metabolic Associated-dysfunction Steatohepatitis (MASH)Forenede Stater
-
Nationwide Children's HospitalEunice Kennedy Shriver National Institute of Child Health and Human Development...RekrutteringPædiatrisk Sepsis-induceret Multiple Organ Dysfunction Syndrome (MODS)Forenede Stater
-
IRCCS Azienda Ospedaliero-Universitaria di BolognaUkendt
-
Singapore National Eye CentreNational University, SingaporeAfsluttet
Kliniske forsøg med paper form
-
University of Alabama at BirminghamLaboratory Corporation of America; Cahaba Medical Care FoundationRekruttering
-
Seattle Children's HospitalBaylor College of MedicineAfsluttetBronkopulmonal dysplasi | Respiratory Distress Syndrome hos for tidligt fødte spædbørn | Nyfødt primær søvnapnøForenede Stater
-
Brigham and Women's HospitalNational Heart, Lung, and Blood Institute (NHLBI)Rekruttering
-
University of MichiganNational Heart, Lung, and Blood Institute (NHLBI)AfsluttetForhøjet blodtryk | PræeklampsiForenede Stater
-
Fisher and Paykel HealthcareAfsluttetObstruktiv søvnapnø (OSA)New Zealand
-
VA Office of Research and DevelopmentRekrutteringObstruktiv søvnapnø | Stofbrugsforstyrrelse | Post traumatisk stress syndrom | BoligbehandlingsprogramForenede Stater
-
Stanford UniversityAfsluttetSøvnapnø, obstruktivForenede Stater
-
Vastra Gotaland RegionAfsluttetLivskvalitet | Sundhedsadfærd | Dagliglivets aktiviteter | Metabolisk syndrom XSverige
-
Dr. Reddy's Laboratories LimitedUkendt